Pacific Biosciences
PACB
#6557
Rank
HK$5.61 B
Marketcap
HK$18.61
Share price
-5.16%
Change (1 day)
17.78%
Change (1 year)

Earnings for Pacific Biosciences (PACB)

Earnings in 2025 (TTM): -HK$3.92 Billion

According to Pacific Biosciences 's latest financial reports the company's current earnings are HK$0.15 Billion. In 2024 the company made an earning of -HK$2.41 Billion, an increase over its 2023 earnings that were of -HK$2.48 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Pacific Biosciences from 2010 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$3.92 Billion62.59%
2024 -HK$2.41 Billion-2.71%
2023 -HK$2.48 Billion1.24%
2022 -HK$2.45 Billion14.33%
2021 -HK$2.14 Billion-1034.84%
2020 HK$0.22 B-134.95%
2019 -HK$0.66 Billion-17.97%
2018 -HK$0.8 Billion11.25%
2017 -HK$0.72 Billion23.95%
2016 -HK$0.58 Billion134.65%
2015 -HK$0.25 Billion-52.09%
2014 -HK$0.52 Billion-16.56%
2013 -HK$0.62 Billion-16.08%
2012 -HK$0.74 Billion-13.78%
2011 -HK$0.86 Billion-21.76%
2010 -HK$1.1 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Illumina
ILMN
HK$7.74 B-297.73%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoString Technologies
NSTG
-HK$1.24 Billion-68.47%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
HK$79.86 B-2,138.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Luminex
LMNX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
HK$55.23 B-1,510.17%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
HK$3.69 B-194.30%๐Ÿ‡บ๐Ÿ‡ธ USA